Opioid analgesic (PecFent); Benzodiazepine anticonvulsant (Epistatus)

This page covers all Opioid analgesic (PecFent); Benzodiazepine anticonvulsant (Epistatus) drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Mu-opioid receptor (PecFent); GABA-A receptor (Epistatus), GABA-A receptor.

Targets

Mu-opioid receptor (PecFent); GABA-A receptor (Epistatus) · GABA-A receptor

Marketed (1)

• PecFent and Epistatus · Gloucestershire Hospitals NHS Foundation Trust · Pain management (PecFent); Neurology/Seizure disorders (Epistatus)
  PecFent is a fentanyl nasal spray that delivers rapid opioid analgesia through intranasal absorption, while Epistatus is a midazolam buccal liquid that provides rapid seizure termination through GABA-A receptor agonism.

Phase 3 pipeline (1)

• Clobazam Low Dose · Lundbeck LLC · Neurology
  Clobazam is a benzodiazepine that enhances inhibitory GABAergic neurotransmission in the central nervous system to reduce seizure activity.

Patent intelligence

• benzodiazepine anticonvulsant patent landscape — aggregated cliff calendar, attackable patents, originator estates